Xuebijing injection versus placebo for critically ill patients with severe community-acquired pneumonia: a randomized controlled trial: research results and clinical value / 中华危重病急救医学
Chinese Critical Care Medicine
;
(12): 1199-1203, 2019.
Artigo
em Chinês
| WPRIM
| ID: wpr-796499
ABSTRACT
This article is based on the research paper named Xuebijing injection versus placebo for critically ill patients with severe community-acquired pneumonia a randomized controlled trial which was published in Critical Care Medicine (CCM), introducing its study results and relevant clinical value. Moreover, we attached two peer experts' comments on this study for the readers' reference.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Tipo de estudo:
Ensaio Clínico Controlado
Idioma:
Chinês
Revista:
Chinese Critical Care Medicine
Ano de publicação:
2019
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS